Correlation Between Virpax Pharmaceuticals and Neurobo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Virpax Pharmaceuticals and Neurobo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virpax Pharmaceuticals and Neurobo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virpax Pharmaceuticals and Neurobo Pharmaceuticals, you can compare the effects of market volatilities on Virpax Pharmaceuticals and Neurobo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virpax Pharmaceuticals with a short position of Neurobo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virpax Pharmaceuticals and Neurobo Pharmaceuticals.
Diversification Opportunities for Virpax Pharmaceuticals and Neurobo Pharmaceuticals
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Virpax and Neurobo is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and Neurobo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobo Pharmaceuticals and Virpax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virpax Pharmaceuticals are associated (or correlated) with Neurobo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobo Pharmaceuticals has no effect on the direction of Virpax Pharmaceuticals i.e., Virpax Pharmaceuticals and Neurobo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Virpax Pharmaceuticals and Neurobo Pharmaceuticals
Given the investment horizon of 90 days Virpax Pharmaceuticals is expected to under-perform the Neurobo Pharmaceuticals. In addition to that, Virpax Pharmaceuticals is 1.55 times more volatile than Neurobo Pharmaceuticals. It trades about -0.26 of its total potential returns per unit of risk. Neurobo Pharmaceuticals is currently generating about -0.16 per unit of volatility. If you would invest 285.00 in Neurobo Pharmaceuticals on August 27, 2024 and sell it today you would lose (43.00) from holding Neurobo Pharmaceuticals or give up 15.09% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virpax Pharmaceuticals vs. Neurobo Pharmaceuticals
Performance |
| Timeline |
| Virpax Pharmaceuticals |
| Neurobo Pharmaceuticals |
Virpax Pharmaceuticals and Neurobo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virpax Pharmaceuticals and Neurobo Pharmaceuticals
The main advantage of trading using opposite Virpax Pharmaceuticals and Neurobo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virpax Pharmaceuticals position performs unexpectedly, Neurobo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobo Pharmaceuticals will offset losses from the drop in Neurobo Pharmaceuticals' long position.| Virpax Pharmaceuticals vs. Revelation Biosciences | Virpax Pharmaceuticals vs. Palisade Bio | Virpax Pharmaceuticals vs. Virax Biolabs Group | Virpax Pharmaceuticals vs. Quoin Pharmaceuticals Ltd |
| Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |